리브스메드

491000KOSDAQ의료용 기기 제조업

51.8 / 100

Reference Date: 2026-07-24

Financial Score13.5 / 40

News Sentiment21.3 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly up 4.3% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Livsmed develops, manufactures, and sells laparoscopic surgical instruments for minimally invasive surgery, leveraging its proprietary 90° multi-joint technology to offer products like ArtiSential and ArtiSeal. The company has obtained major international certifications and aims to provide comprehensive solutions in the global minimally invasive surgery market.

Number of Employees

334people

Average Salary

44.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 20.044.0Point

PBR

5.31Industry Average 1.140.0Point

4.7x industry avg (risky)

ROE

-20.75Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

4.02Industry Average 11.656.5Point

Half of industry avg (excellent)

Trend 3.0 / 10 points

Revenue Growth Rate

1.5 / 3

Operating Profit Growth Rate

1.5 / 3

ROE Trend

0.0 / 4

Detailed News Sentiment

6 totalPositive 6Neutral 0Negative 0Average Sentiment Score 85

Positive
"휴머노이드 수술 첫 성공"…손 끝엔 K-의료기기
UC 샌디에이고 연구팀의 휴머노이드 수술 성공 소식으로 리브스메드의 의료기기 기술력이 인정받아 긍정적 영향 예상.
Positive
리브스메드 "세계 첫 성공 휴머노이드 수술에 '아티센셜' 채택"
리브스메드의 다관절 수술기구 아티센셜이 세계 최초의 성공적인 휴머노이드 로봇 수술에 활용되어 기술적 우위를 입증했습니다.
Positive
용인시, 세계 4대 반도체 장비 공룡 품다…어플라이드 머티어리얼즈 .....
용인시가 글로벌 반도체 장비 리더인 어플라이드 머티리얼즈를 유치함으로써 지역의 반도체 산업 경쟁력을 강화했다.

Detailed Momentum

52-week position1.0Point

Near 52w low (9%, downtrend)

Current 38,400Won52-week high 91,30052-week low 33,050

1-month return4.0Point

1m +4.35% (slight rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-10
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-10
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-10
Neutral주식등의대량보유상황보고서(일반)2026-07-10
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-10